Basics |
Verve Therapeutics, Inc.
|
IPO Date: |
July 17, 2021 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$427.44M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.81 | 3.94%
|
Avg Daily Range (30 D): |
$0.23 | 4.71%
|
Avg Daily Range (90 D): |
$0.26 | 4.72%
|
Institutional Daily Volume |
Avg Daily Volume: |
.98M |
Avg Daily Volume (30 D): |
2.7M |
Avg Daily Volume (90 D): |
2.46M |
Trade Size |
Avg Trade Size (Sh.): |
81 |
Avg Trade Size (Sh.) (30 D): |
114 |
Avg Trade Size (Sh.) (90 D): |
118 |
Institutional Trades |
Total Inst.Trades: |
1,407 |
Avg Inst. Trade: |
$2.02M |
Avg Inst. Trade (30 D): |
$1.13M |
Avg Inst. Trade (90 D): |
$1.1M |
Avg Inst. Trade Volume: |
.13M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.41M |
Avg Closing Trade (30 D): |
$1.11M |
Avg Closing Trade (90 D): |
$1.07M |
Avg Closing Volume: |
160.31K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-2.11
|
$-.35
|
$-.58
|
Diluted EPS
|
$-2.11
|
$-.35
|
$-.58
|
Revenue
|
$ 59.61M
|
$ 32.98M
|
$ 13.08M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -181.01M
|
$ -31.03M
|
$ -50.04M
|
Operating Income / Loss
|
$ -208.45M
|
$ -36.64M
|
$ -56.07M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -47.65M
|
$ -76.01M
|
$ 13.85M
|
PE Ratio
|
|
|
|
|
|
|